As high as 43% of employers with at least 5,000 employees reported offering such coverage an almost 54% increase compared to the prior years results
Beyond current indications, Alberta Blue Cross identifies potential future expanded uses including: Metabolic dysfunction-associated steatohepatitis (MASH) [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Obstructive sleep apnea (OSA) [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] The insurer characterizes the developing GLP-1 pipeline as robust, with treatments described as more effective, broader in use, and longer between doses [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]
Avoid repeated warming, cooling, or freezethaw cycles, as temperature fluctuations may affect stability
Ascidian is eligible for up to $1.9 billion in payments, including prepayments, development and commercialization milestone payments, and tiered royalties based on global sales
Why Yummy Gummy
PlexusDx's pricing structureflat monthly rates regardless of dose escalationremoves barriers to consistent, personalized care